Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MycoDART
Carrollton, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
MycoDART has developed and commercialized the MycoDART-PCR real-time PCR diagnostic panels, which provide species-level identification of multiple Candida and Aspergillus species from clinical samples within 4–6 hours and are used clinically and in pre-clinical research for early and rapid detection of deadly fungal infections, particularly in high-risk populations such as transplant and immunocompromised patients.[1][2][4][5]
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Molecular Diagnostics
02
Partnerships
RealTime Laboratories (clinical molecular laboratory and co-developer/commercial partner for MycoDART-PCR tests)[3][5]
Beyond the preview
Go deeper on MycoDART.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MycoDART.